Bienvenue sur le nouveau site de www.paris-communiques.com
Les communiqués de presse en direct Paris & Ile de France
Communiqué de presse : santé

ImaBiotech's first worldwide patent has been granted for its quantification innovation in MSI

Imabiotech

Communiqué le 31/03/2016

ImaBiotech, a CRO company developing and offering new imaging technologies, applications, and software, announces today that the company has been granted a patent in USA, France, Australia and China for its lead innovation on quantitative MS Imaging (QMSI) and the development of the associated software, Multimaging.

Specifically, the QMSI patent covers the working method, the strategy, the method of validation, the application, and the use of quantitative Mass Spectrometry Imaging including MALDI Imaging.

“This is a positive recognition of our hard work,” said Jonathan Stauber, Chief Executive Officer of ImaBiotech. “The progress and recognition of our QMSI and MALDI Imaging services are now supporting ImaBiotech's growth and development of our US operations and facility. This patent coverage is critical for our ongoing efforts.”

Contact presse :
Edma Fontaine,
ImaBiotech
Communication Manager
T: +33 (0) 320 164 091

En savoir plus : https://www.imabiotech.com/


Retour page précédente

Pub
Max Chaoul Couture, robes de mariées - collection des 20ans Max Chaoul Couture, collection de robes mariées
Lien partenaire
MinibusParis.com
Service de location de minibus à Paris
Communiqués les plus consultés :
    Paris-communiques.com dans les autres régions
    Pour retrouver l'ensemble des communiqués de presse diffusés sur notre plateforme :
    1001PARIS
    Annuaire Web Paris